7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2012-06-30 2012-03-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 
      
    		                                                        
      assets
    		                                                        
      ​
    		                                                        
      current assets
    		                                                        
      cash and cash equivalents
    		158,134,000 132,469,000 171,668,000 115,694,000 164,186,000 228,678,000 134,188,000 114,888,000 267,720,000 230,010,000 543,484,000 231,731,000 118,366,000 108,075,000 92,360,000 78,229,000 58,590,000 82,763,000 131,954,000 67,329,000 68,310,000 160,614,000 52,540,000 13,969,000 38,889,000 76,912,000 54,093,000 82,152,000 80,738,000 246,017,000 297,082,000 145,373,000 163,380,000 114,285,000 107,099,000 106,717,000 92,895,000 101,222,000 13,642,000 10,210,000 12,556,290 111,280,443 44,909,147 18,440,361 17,943,877 19,672,177 129,804 15,739  910,608 268,565 722,994 1,292,469 795,943 209,263 311,799 
      trade accounts receivable
    		66,761,000 59,938,000 70,938,000 69,340,000 55,768,000 31,604,000 234,000 151,000  33,000                                               
      short-term investments
    		142,669,000 168,714,000 188,045,000 208,087,000 233,302,000 183,864,000 222,007,000 164,979,000 93,654,000 20,884,000 82,808,000 240,114,000 241,807,000 316,383,000 389,829,000 426,181,000 517,859,000 573,605,000 461,976,000 562,108,000 645,838,000 611,265,000 193,112,000 293,112,000 322,985,000 327,241,000 385,925,000 386,371,000 179,262,000 30,082,000    14,732,000 40,098,000 59,753,000 86,387,000                    
      inventory
    		51,710,000 49,833,000 65,545,000 51,520,000 38,578,000 27,854,000 17,617,000 10,372,000 9,195,000 9,720,000                                               
      prepaid expenses and other assets
    		9,817,000 11,546,000 15,894,000 12,377,000 6,744,000 10,183,000 11,487,000 17,458,000 12,017,000 14,231,000 11,489,000 7,271,000 9,711,000 7,135,000 7,779,000 3,546,000 6,577,000 10,272,000 11,288,000 6,663,000 9,442,000 10,775,000 10,729,000 9,412,000    6,851,000 5,863,000 3,682,000 5,644,000                          
      total current assets
    		429,091,000 422,500,000 512,649,000 457,018,000 498,578,000 482,257,000 385,533,000 307,848,000 382,586,000 274,878,000 637,781,000 479,116,000 369,884,000 431,593,000 489,968,000 507,956,000 583,026,000 666,640,000 605,218,000 636,100,000 723,590,000 782,654,000 256,381,000 316,493,000 367,307,000 410,938,000 444,753,000 475,374,000 265,863,000 279,781,000 302,726,000 149,290,000 171,375,000 135,434,000 152,593,000 169,512,000 180,556,000 192,350,000 103,977,000 110,391,000 112,714,536 111,409,326 44,975,281 18,519,571 18,067,968 19,845,893 138,682 24,367 34,050 3,298,108 326,065 788,286 1,300,916 801,093 214,413 316,949 
      property and equipment
    		126,650,000 122,473,000 111,584,000 109,081,000 112,520,000 110,960,000 111,789,000 114,030,000 113,142,000 112,549,000 109,923,000 105,232,000 100,746,000 101,154,000 102,757,000 100,938,000 88,034,000 80,120,000 72,750,000 59,159,000 39,112,000 18,726,000 13,607,000 8,536,000 5,856,000 4,472,000 3,504,000 2,683,000 2,640,000 2,706,000 2,247,000 2,450,000 2,595,000 2,578,000 2,796,000 2,374,000 1,769,000 1,192,000 1,676,000 1,833,000 2,025,056 2,128,260 1,531,566 15,771 14,628 27,756 29,944   18,803 16,299      
      intangible assets
    		285,208,000 296,253,000 285,356,000 282,398,000 306,639,000 295,299,000 294,303,000 229,258,000 223,610,000 235,511,000                                               
      operating lease right-of-use assets
    		48,763,000 49,949,000 50,903,000 55,201,000 66,743,000 69,123,000 71,516,000 62,515,000 66,265,000 67,631,000 70,431,000 73,015,000 68,268,000 70,845,000 73,475,000 68,983,000 72,423,000 52,508,000 55,131,000 54,756,000 10,682,000 7,480,000 9,305,000 10,695,000 13,738,000 11,719,000 9,957,000                              
      restricted cash
    		5,965,000 5,944,000 559,000 6,359,000 6,355,000 74,000 6,430,000 66,430,000 66,430,000 66,430,000 6,430,000 6,430,000 6,430,000 6,430,000 6,084,000 6,084,000 6,084,000 6,084,000 6,084,000 5,525,000 5,525,000 5,525,000 5,525,000 5,450,000 5,450,000 5,450,000                        2,320,000       
      long-term assets
    		9,271,000 10,318,000 426,000 369,000 280,000 327,000 259,000 270,000 282,000 294,000 202,000 189,000 596,000 856,000 1,266,000 1,784,000 1,011,000 1,150,000 1,163,000 12,918,000 3,385,000 3,182,000 3,480,000 3,481,000 3,395,000 3,345,000 3,288,000 2,764,000 2,331,000 2,264,000 2,275,000 3,633,000                         
      total assets
    		904,948,000 907,437,000 966,740,000 910,426,000 991,115,000 964,322,000 869,830,000 780,351,000 852,315,000 757,293,000 824,767,000 663,982,000 545,924,000 610,878,000 701,251,000 777,333,000 828,825,000 852,790,000 750,573,000 768,458,000 782,294,000 817,567,000 288,298,000 344,655,000 395,746,000 435,924,000 461,502,000 480,821,000 270,834,000 284,751,000 307,248,000 155,373,000 173,970,000 138,012,000 155,389,000 171,886,000 182,325,000 193,542,000 105,653,000 112,224,000 114,739,592 113,537,586 46,506,847 18,535,342 18,082,596 19,873,649 168,626 65,611 76,847 3,438,596 466,166 930,205 1,460,952 1,020,235 433,729 536,438 
      liabilities and stockholders’ equity
    		                                                        
      current liabilities
    		                                                        
      accounts payable
    		31,237,000 32,004,000 28,489,000 27,509,000 31,686,000 20,416,000 25,700,000 33,123,000 19,274,000 31,157,000 31,572,000 26,603,000 24,255,000 20,009,000 20,454,000 27,377,000 12,181,000 21,914,000 13,369,000 13,513,000 24,794,000 10,238,000 10,614,000 15,567,000 9,921,000 12,782,000 7,589,000 2,739,000 6,014,000 5,196,000 6,576,000 1,232,000 2,905,000 3,695,000 2,174,000 863,000 228,000 725,000 958,000 1,161,000 1,156,922 1,107,370 1,248,413 440,550 286,325 412,976 1,550,865 609,266 504,252 206,864 130,638 72,493 30,292 25,492 15,777 17,061 
      accrued expenses and other liabilities
    		87,267,000 89,081,000 84,705,000 81,936,000                                                     
      note payable - current
    		1,000,000 1,000,000 1,000,000                                                      
      operating lease liabilities
    		6,281,000 7,070,000 8,499,000 12,896,000 11,551,000 11,436,000 11,078,000 7,777,000 10,468,000 10,866,000 12,614,000 12,587,000 7,171,000 6,483,000 7,710,000 5,057,000        7,252,000 8,370,000 7,484,000 6,059,000                              
      total current liabilities
    		125,785,000 129,155,000 122,693,000 122,341,000 118,056,000 93,639,000 83,214,000 110,306,000 90,955,000 88,643,000 87,274,000 91,485,000 79,245,000 64,192,000 77,075,000 89,200,000 64,766,000 60,534,000 55,059,000 54,871,000 64,390,000 54,905,000 39,545,000 39,084,000 34,613,000 33,836,000 22,137,000 14,398,000 16,674,000 14,182,000 14,690,000 9,892,000 8,529,000 8,860,000 5,503,000 4,968,000 3,194,000 4,606,000 1,630,000 2,855,000 1,866,196 1,910,717 1,661,760 1,156,472 1,109,486 2,269,932 3,509,085 16,683,973 17,335,298 9,129,321 1,870,111 771,114 822,867 572,222 15,777 35,198 
      non-current liabilities
    		                                                        
      operating lease liabilities – non-current
    		45,211,000 45,096,000 44,220,000 44,365,000 66,389,000 69,246,000 72,291,000 67,085,000 68,009,000 68,844,000 69,612,000 71,859,000 71,943,000                                            
      deferred tax liabilities
    		31,665,000 34,698,000 31,962,000 32,315,000 32,215,000 31,897,000 33,301,000 17,347,000 18,343,000 20,237,000                                               
      long-term note payable
    		   1,000,000 1,000,000 1,000,000 1,000,000 1,000,000 1,000,000 1,000,000 1,000,000 1,000,000 1,000,000 1,000,000 1,000,000 1,000,000 1,000,000 1,000,000 1,000,000                                      
      total non-current liabilities
    		76,876,000 79,794,000 76,182,000 77,680,000 99,604,000 102,143,000 106,592,000 85,432,000 87,352,000 90,081,000 70,612,000 72,859,000 72,943,000 73,996,000 72,184,000 66,474,000 65,729,000 47,843,000 48,083,000 57,089,000 6,063,000 4,353,000 5,440,000 6,600,000 6,070,000 4,666,000 4,433,000 230,000                             
      total liabilities
    		202,661,000 208,949,000 198,875,000 200,021,000 217,660,000 195,782,000 189,806,000 195,738,000 178,307,000 178,724,000 157,886,000 164,344,000 152,188,000 138,188,000 149,259,000 155,674,000 130,495,000 108,377,000 103,142,000 111,960,000 70,453,000 59,258,000 44,985,000 45,684,000 40,683,000 38,502,000 26,570,000 14,628,000                             
      commitments and contingencies
    		                                                        
      stockholders’ equity
    		                                                        
      series a convertible preferred stock, 0.001 par value; 17,000 shares designated, 194 shares issued and outstanding as of september 30, 2025 and december 31, 2024
    		                                                        
      series b convertible preferred stock, 0.001 par value; 11,500,000 shares designated, 1,932,667 and 2,842,158 shares issued and outstanding as of september 30, 2025 and december 31, 2024 respectively
    		2,000                                                        
      common stock
    		16,000 14,000 14,000 13,000 13,000 12,000 12,000 11,000 11,000 9,000 9,000 8,000 7,000 7,000 7,000 7,000 7,000 7,000 6,000 6,000 6,000 6,000 5,000 5,000 5,000 5,000 5,000 5,000 4,000 4,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 2,000 2,000 1,964 1,870        3,291 3,236 2,945 3,068    
      accumulated other comprehensive loss
    		16,103,000 20,859,000 6,294,000 -1,046,000 16,242,000 526,000 116,000    -126,000 -902,000 -2,038,000 -2,697,000 -2,343,000         220,000    -42,000 -120,000 -3,000                           
      additional paid-in capital
    		3,389,792,000 3,289,986,000 3,262,270,000 3,095,987,000 3,063,190,000 2,990,451,000 2,805,244,000 2,594,448,000 2,579,087,000 2,360,468,000 2,342,703,000 2,068,867,000 1,858,783,000 1,838,778,000 1,818,377,000 1,794,695,000 1,771,440,000 1,731,363,000 1,552,968,000 1,486,662,000 1,473,472,000 1,461,207,000 882,599,000 869,354,000 861,859,000 854,596,000 844,789,000 838,984,000 594,455,000 576,917,000 568,243,000 394,651,000 388,756,000 330,318,000 327,673,000 323,994,000 320,140,000 311,268,000 207,950,000 204,929,000 200,832,015 193,239,795 121,160,415 86,029,444 83,346,665 81,884,897 40,582,801 16,357,027 15,887,542 13,330,974 11,799,331 2,402,918 2,317,493 1,385,534 641,755 640,414 
      accumulated deficit
    		-2,703,626,000 -2,612,373,000 -2,500,715,000 -2,384,552,000 -2,305,993,000 -2,222,452,000 -2,125,351,000 -2,012,375,000 -1,895,996,000 -1,782,236,000 -1,675,708,000 -1,568,338,000 -1,463,019,000 -1,363,401,000 -1,264,052,000 -1,172,445,000 -1,073,115,000 -986,993,000 -905,642,000 -830,193,000 -761,796,000 -703,225,000 -640,207,000 -570,612,000 -507,044,000 -457,557,000 -410,006,000 -372,760,000 -340,185,000 -306,355,000 -275,695,000 -249,180,000 -223,326,000 -201,177,000 -177,800,000 -157,116,000 -141,428,000 -122,669,000 -104,222,000 -95,845,000 -88,227,444 -81,859,953 -76,561,894 -68,896,868 -66,786,699 -64,527,185 -44,569,042 -33,476,539 -33,149,255 -19,024,990 -13,206,512 -2,246,772 -1,682,476 -940,554 -226,797 -142,168 
      total stockholders’ equity
    		702,287,000 698,488,000 767,865,000 710,405,000 773,455,000 768,540,000 680,024,000 584,613,000 674,008,000 578,569,000 666,881,000 499,638,000 393,736,000 472,690,000 551,992,000 621,659,000 698,330,000 744,413,000 647,431,000 656,498,000 711,841,000 758,309,000 243,313,000 298,971,000 355,063,000 397,422,000 434,932,000 466,193,000 254,160,000 270,569,000 292,558,000 145,481,000 165,441,000 129,152,000 149,886,000 166,918,000 179,131,000 188,936,000  109,369,000 112,873,396          -1,403,945 159,091 638,085    
      total liabilities and stockholders’ equity
    		904,948,000 907,437,000 966,740,000 910,426,000 991,115,000 964,322,000 869,830,000 780,351,000 852,315,000 757,293,000 824,767,000 663,982,000 545,924,000 610,878,000 701,251,000 777,333,000 828,825,000 852,790,000 750,573,000 768,458,000 782,294,000 817,567,000 288,298,000 344,655,000 395,746,000 435,924,000 461,502,000 480,821,000 270,834,000 284,751,000 307,248,000 155,373,000 173,970,000 138,012,000 155,389,000 171,886,000 182,325,000 193,542,000  112,224,000 114,739,592          466,166 930,205 1,460,952    
      series a convertible preferred stock, 0.001 par value; 17,000 shares designated, 194 shares issued and outstanding as of june 30, 2025 and december 31, 2024
    		                                                        
      series b convertible preferred stock, 0.001 par value; 11,500,000 shares designated, 1,932,667 and 2,842,158 shares issued and outstanding as of june 30, 2025 and december 31, 2024 respectively
    		 2,000                                                       
      series a convertible preferred stock, 0.001 par value; 17,000 shares designated, 194 shares issued and outstanding as of march 31, 2025 and december 31, 2024
    		                                                        
      series b convertible preferred stock, 0.001 par value; 11,500,000 shares designated, 1,932,667 and 2,842,158 shares issued and outstanding as of march 31, 2025 and december 31, 2024 respectively
    		  2,000                                                      
      series a convertible preferred stock, 0.001 par value; 17,000 shares designated, 194 shares issued and outstanding as of december 31, 2024 and december 31, 2023
    		                                                        
      series b convertible preferred stock, 0.001 par value; 11,500,000 shares designated, 2,842,158 shares issued and outstanding as of december 31, 2024 and december 31, 2023
    		   3,000                                                     
      accrued expenses
    		    74,819,000 61,787,000 46,436,000 69,406,000 61,213,000 46,620,000 43,088,000 52,295,000 47,819,000 37,700,000 48,911,000 56,766,000 45,969,000 34,192,000 35,774,000 35,074,000 32,400,000 38,794,000 22,500,000 16,265,000 16,322,000 13,570,000 8,489,000 11,659,000 10,660,000 8,986,000 8,114,000 8,660,000 5,624,000 5,165,000 3,329,000 4,105,000 2,966,000 3,881,000 586,000 1,608,000 623,774 717,847 327,847 715,922 823,161 1,856,956 1,958,220 502,347 279,480        
      series a convertible preferred stock, 0.001 par value; 17,000 shares designated, 194 shares issued and outstanding as of september 30, 2024 and december 31, 2023
    		                                                        
      series b convertible preferred stock, 0.001 par value; 11,500,000 shares designated, 2,842,158 shares issued and outstanding as of september 30, 2024 and december 31, 2023
    		    3,000                                                    
      series a convertible preferred stock, 0.001 par value; 17,000 shares designated, 194 shares issued and outstanding as of june 30, 2024 and december 31, 2023
    		                                                        
      series b convertible preferred stock, 0.001 par value; 11,500,000 shares designated, 2,842,158 shares issued and outstanding as of june 30, 2024 and december 31, 2023
    		     3,000                                                   
      series a convertible preferred stock, 0.001 par value; 17,000 shares designated, 194 shares issued and outstanding as of march 31, 2024 and december 31, 2023
    		                                                        
      series b convertible preferred stock, 0.001 par value; 11,500,000 shares designated, 2,842,158 shares issued and outstanding as of march 31, 2024 and december 31, 2023
    		      3,000                                                  
      series a convertible preferred stock, 0.001 par value; 17,000 shares designated, 194 shares issued and outstanding as of december 31, 2023 and december 31, 2022
    		                                                        
      series b convertible preferred stock, 0.001 par value; 11,500,000 shares designated, 2,842,158 shares issued and outstanding as of december 31, 2023 and december 31, 2022
    		       3,000                                                 
      accumulated other comprehensive income
    		       2,526,000 -9,097,000 325,000      -601,000 -5,000 33,000 96,000 19,000 155,000 317,000 912,000  239,000 372,000 138,000        2,000 29,000 163,000 78,000 48,000 38,000 21,704                
      series a convertible preferred stock, 0.001 par value; 17,000 shares designated, 194 shares issued and outstanding as of september 30, 2023 and december 31, 2022
    		                                                        
      series b convertible preferred stock, 0.001 par value; 11,500,000 shares designated, 2,842,158 shares issued and outstanding as of september 30, 2023 and december 31, 2022
    		        3,000                                                
      series a convertible preferred stock, 0.001 par value; 17,000 shares designated, 194 shares issued and outstanding as of june 30, 2023 and december 31, 2022
    		                                                        
      series b convertible preferred stock, 0.001 par value; 11,500,000 shares designated, 2,842,158 shares issued and outstanding as of june 30, 2023 and december 31, 2022
    		         3,000                                               
      series a convertible preferred stock, 0.001 par value; 17,000 shares designated, 194 shares issued and outstanding as of march 31, 2023 and december 31, 2022
    		                                                        
      series b convertible preferred stock, 0.001 par value; 11,500,000 shares designated, 2,842,158 shares issued and outstanding as of march 31, 2023 and december 31, 2022
    		          3,000                                              
      long-term investments
    		              27,701,000 91,588,000 78,247,000 46,288,000 10,227,000                                      
      series a convertible preferred stock, 0.001 par value; 17,000 shares designated, 194 shares issued and outstanding as of december 31, 2022 and december 31, 2021
    		                                                        
      series b convertible preferred stock, 0.001 par value; 11,500,000 shares designated, 2,842,158 shares issued and outstanding as of december 31, 2022 and december 31, 2021
    		           3,000                                             
      series a convertible preferred stock, 0.001 par value; 17,000 shares designated, 194 shares issued and outstanding as of september 30, 2022 and december 31, 2021
    		                                                        
      series b convertible preferred stock, 0.001 par value; 11,500,000 shares designated, 2,842,158 shares issued and outstanding as of september 30, 2022 and december 31, 2021
    		            3,000                                            
      operating lease liabilities – noncurrent
    		             72,996,000 71,184,000 65,474,000 64,729,000 46,843,000 47,083,000 45,375,000 3,711,000 2,001,000 3,088,000                                  
      series a convertible preferred stock, 0.001 par value; 17,000 shares designated, 194 shares issued and outstanding as of june 30, 2022 and december 31, 2021
    		                                                        
      series b convertible preferred stock, 0.001 par value; 11,500,000 shares designated, 2,842,158 shares issued and outstanding as of june 30, 2022 and december 31, 2021
    		             3,000                                           
      series a convertible preferred stock, 0.001 par value; 17,000 shares designated, 194 shares issued and outstanding as of march 31, 2022 and december 31, 2021
    		                                                        
      series b convertible preferred stock, 0.001 par value; 11,500,000 shares designated, 2,842,158 shares issued and outstanding as of march 31, 2022 and december 31, 2021
    		              3,000                                          
      other liabilities
    		                   11,714,000 2,352,000 2,352,000 2,352,000 2,352,000 53,000 53,000 53,000                              
      series a convertible preferred stock, 0.001 par value; 17,000 shares designated, 194 shares issued and outstanding as of december 31, 2021 and december 31, 2020
    		                                                        
      series b convertible preferred stock, 0.001 par value; 11,500,000 shares designated, 2,842,158 and 3,581,119 shares issued and outstanding as of december 31, 2021 and december 31, 2020
    		               3,000                                         
      operating lease liabilities - current
    		                6,616,000 4,428,000 5,916,000 6,284,000 7,196,000 5,873,000 6,431,000                                  
      series a convertible preferred stock, 0.001 par value; 17,000 shares designated, 194 shares issued and outstanding as of september 30, 2021 and december 31, 2020
    		                                                        
      series b convertible preferred stock, 0.001 par value; 11,500,000 shares designated, 2,842,158 and 3,581,119 shares issued and outstanding as of september 30, 2021 and december 31, 2020, respectively
    		                3,000                                        
      series a convertible preferred stock, 0.001 par value; 17,000 shares designated, 194 shares issued and outstanding as of june 30, 2021 and december 31, 2020
    		                                                        
      series b convertible preferred stock, 0.001 par value; 11,500,000 shares designated, 2,842,158 and 3,581,119 shares issued and outstanding as of june 30, 2021 and december 31, 2020, respectively
    		                 3,000                                       
      series a convertible preferred stock, 0.001 par value; 17,000 shares designated, 194 shares issued and outstanding as of march 31, 2021 and december 31, 2020
    		                                                        
      series b convertible preferred stock, 0.001 par value; 11,500,000 shares designated, 2,842,158 and 3,581,119 shares issued and outstanding as of march 31, 2021 and december 31, 2020, respectively
    		                  3,000                                      
      series a convertible preferred stock, 0.001 par value; 17,000 shares designated, 194 shares issued and outstanding as of december 31, 2020 and december 31, 2019
    		                                                        
      series b convertible preferred stock, 0.001 par value; 11,500,000 shares designated, 3,581,119 shares issued and outstanding as of december 31, 2020 and december 31, 2019
    		                   4,000                                     
      series a convertible preferred stock, 0.001 par value; 17,000 shares designated, 194 shares issued and outstanding as of september 30, 2020 and december 31, 2019
    		                                                        
      series b convertible preferred stock, 0.001 par value; 11,500,000 shares designated, 3,581,119 shares issued and outstanding as of september 30, 2020 and december 31, 2019
    		                    4,000                                    
      series a convertible preferred stock, 0.001 par value; 17,000 shares designated, 194 shares issued and outstanding as of june 30, 2020 and december 31, 2019
    		                                                        
      series b convertible preferred stock, 0.001 par value; 11,500,000 shares designated, 3,581,119 shares issued and outstanding as of june 30, 2020 and december 31, 2019
    		                     4,000                                   
      series a convertible preferred stock, 0.001 par value; 17,000 shares designated, 194 shares issued and outstanding as of march 31, 2020 and december 31, 2019
    		                                                        
      series b convertible preferred stock, 0.001 par value; 11,500,000 shares designated, 3,581,119 shares issued and outstanding as of march 31, 2020 and december 31, 2019
    		                      4,000                                  
      series a convertible preferred stock, 0.001 par value; 17,000 shares designated, 194 shares issued and outstanding as of december 31, 2019 and december 31, 2018
    		                                                        
      series b convertible preferred stock, 0.001 par value; 11,500,000 shares designated, 3,581,119 and 5,854,845 shares issued and outstanding as of december 31, 2019 and december 31, 2018
    		                       4,000                                 
      prepaid expenses and other current assets
    		                        5,433,000 6,785,000 4,735,000     3,917,000 7,995,000 6,417,000 5,396,000 3,042,000 1,274,000 782,000 277,000    66,134  114,091            
      series a convertible preferred stock, 0.001 par value; 17,000 shares designated, 194 shares issued and outstanding as of september 30, 2019 and december 31, 2018
    		                                                        
      series b convertible preferred stock, 0.001 par value; 11,500,000 shares designated; 3,581,119 and 5,854,845 shares issued and outstanding as of september 30, 2019 and december 31, 2018
    		                        4,000                                
      series a convertible preferred stock, 0.001 par value; 17,000 shares authorized, 194 shares issued and outstanding as of june 30, 2019 and december 31, 2018
    		                                                        
      series b convertible preferred stock, 0.001 par value; 50,000,000 shares authorized; 5,854,845 shares issued and outstanding as of june 30, 2019 and december 31, 2018
    		                         6,000                               
      series a convertible preferred stock, 0.001 par value; 17,000 shares authorized, 194 shares issued and outstanding as of march 31, 2019; and december 31, 2018
    		                                                        
      series b convertible preferred stock, 0.001 par value; 11,500,000 shares authorized; 5,854,845 shares issued and outstanding as of march 31, 2019 and december 31, 2018 (aggregate liquidation value of 27,811);
    		                          6,000                              
      deferred rent
    		                           230,000                             
      series a convertible preferred stock, 0.001 par value; 17,000 shares authorized, 194 shares issued and outstanding as of december 31, 2018; 1,694 shares issued and outstanding december 31, 2017
    		                                                        
      series b convertible preferred stock, 0.001 par value; 11,500,000 shares authorized; 5,854,845 shares issued and outstanding as of december 31, 2018; 7,378,241 shares issued and outstanding december 31, 2017 (aggregate liquidation value of 27,811);
    		                           6,000                             
      series a convertible preferred stock, 0.001 par value; 17,000 shares authorized, 194 shares issued and outstanding as of september 30, 2018; 1,694 shares issued and outstanding december 31, 2017
    		                                                        
      series b convertible preferred stock, 0.001 par value; 11,500,000 shares authorized; 5,854,845 shares issued and outstanding as of september 30, 2018; 7,378,241 shares issued and outstanding december 31, 2017 (aggregate liquidation value of 27,811);
    		                            6,000                            
      series a convertible preferred stock, 0.001 par value; 17,000 shares authorized, 194 shares issued and outstanding as of june 30, 2018; 1,694 shares issued and outstanding december 31, 2017
    		                                                        
      series b convertible preferred stock, 0.001 par value; 11,500,000 shares authorized; 6,127,692 shares issued and outstanding as of june 30, 2018; 7,378,241 shares issued and outstanding december 31, 2017 (aggregate liquidation value of 29,107);
    		                             6,000                           
      series a convertible preferred stock, 0.001 par value; 17,000 shares authorized, 1,694 shares issued and outstanding, as of march 31, 2018 and december 31, 2017
    		                                                        
      series b convertible preferred stock, 0.001 par value; 11,500,000 shares authorized, 7,378,241 issued and outstanding as of march 31, 2018 and december 31, 2017
    		                              7,000                          
      series a convertible preferred stock, 0.001 par value; 17,000 shares authorized, 1,694 shares issued and outstanding, as of december 31, 2017 and december 31, 2016, respectively
    		                                                        
      series b convertible preferred stock, 0.001 par value; 11,500,000 shares authorized, 7,378,241 and 7,946,673 shares issued and outstanding as of december 31, 2017 and december 31, 2016, respectively
    		                               7,000                         
      series a convertible preferred stock, 0.001 par value; 17,000 shares authorized, 1,694 shares issued and outstanding, as of september 30, 2017 and december 31, 2016, respectively
    		                                                        
      series b convertible preferred stock, 0.001 par value; 11,500,000 shares authorized, 7,946,673 shares issued and outstanding as of september 30, 2017 and december 31, 2016, respectively
    		                                8,000                        
      series a convertible preferred stock, 0.001 par value; 17,000 shares authorized, 1,694 shares issued and outstanding, as of june 30, 2017 and december 31, 2016, respectively
    		                                                        
      series b convertible preferred stock, 0.001 par value; 11,500,000 shares authorized, 7,946,673 shares issued and outstanding as of june 30, 2017 and december 31, 2016, respectively
    		                                 8,000                       
      series a convertible preferred stock, 0.001 par value; 17,000 shares authorized, 1,694 shares issued and outstanding, as of march 31, 2017 and december 31, 2016, respectively
    		                                                        
      series b convertible preferred stock, 0.001 par value; 11,500,000 shares authorized, 7,946,673 shares issued and outstanding as of march 31, 2017 and december 31, 2016, respectively
    		                                  8,000                      
      shares authorized, 62,350,149 and 62,248,074 shares issued and outstanding as of march 31, 2017 and december 31, 2016, respectively
    		                                                        
      series a convertible preferred stock, 0.001 par value; 17,000 shares authorized, 1,694 shares issued and outstanding, respectively
    		                                                        
      series b convertible preferred stock, 0.001 par value; 11,500,000 shares authorized, 7,946,673 and 0 shares issued and outstanding as of december 31, 2016 and 2015, respectively
    		                                   8,000                     
      shares authorized, 62,248,074 and 48,547,720 shares issued and outstanding as of december 31, 2016 and 2015, respectively
    		                                                        
      series a preferred stock, 0.001 par value; 17,000 shares authorized, 1,694 shares issued and outstanding, respectively
    		                                                        
      series b preferred stock, 0.001 par value; 11,500,000 shares authorized, 7,946,673 and 0 shares issued and outstanding (aggregate liquidation value of 37,747), respectively
    		                                    8,000                    
      common stock to be issued, 303,125 shares
    		                                    245,000 245,000 245,000  245,153 245,153 245,153 245,153 245,153 245,153 245,153          
      money market funds
    		                                     19,744,000 19,945,000 20,562,000 7,476,855                
      short-term investments available for sale
    		                                     70,602,000 70,113,000 79,374,000 92,302,982                
      series b preferred stock, 0.001 par value; 11,500,000 shares authorized, 11,368,633 and 0 shares issued and outstanding (aggregate liquidation value of 54,001), respectively
    		                                     11,000                   
      liabilities and stockholders' equity
    		                                                        
      accrued payable to officers and former directors
    		                                      86,000 86,000 85,500 85,500 85,500              
      stockholders' equity
    		                                                        
      preferred stock, 0.001 par value; 50,000,000 shares authorized, 1,694 and 5,694 shares issued and outstanding, respectively
    		                                                        
      total stockholders' equity
    		                                      104,023,000   111,626,869 44,845,087 17,378,870 16,806,053 17,603,717    -5,690,725    448,013 417,952 501,240 
      total liabilities and stockholders' equity
    		                                      105,653,000   113,537,586 46,506,847 18,535,342 18,082,596 19,873,649    3,438,596    1,020,235 433,729 536,438 
      prepaid and other current assets
    		                                       245,000                 
      preferred stock, 0.001 par value; 50,000,000 shares authorized, 3,694 shares and 5,694 shares issued and outstanding, respectively
    		                                        4 4               
      common stock to be issued, 245,153 shares
    		                                       245,000                 
      prepaid expenses and deposits
    		                                        378,409 128,883               
      preferred stock, 0.001 par value; 50,000,000 shares authorized,
    		                                                        
      5,694 shares and 17,000 shares issued and outstanding, respectively
    		                                          6              
      33,750,188 and 20,023,958 shares issued and outstanding, respectively
    		                                          1,407              
      deposits
    		                                           9,744 10,000 15,000 5,000          
      prepaid expenses
    		                                           69,466  158,716 3,878     7,792 3,447 5,000 5,000 5,000 
      5,800 shares and 17,000 shares issued and outstanding, respectively
    		                                           6             
      27,226,350 and 20,023,958 shares issued and outstanding, respectively
    		                                           1,135             
      the accompanying notes are an integral part of these financial statements.
    		                                                        
      accrued compensation payable in shares of stock
    		                                            167,057            
      13,300 shares and 17,000 shares issued and outstanding, respectively
    		                                            13            
      22,092,958 and 20,023,958 shares issued and outstanding, respectively
    		                                            921            
      7% senior secured convertible promissory notes
    		                                                        
      12% secured promissory note
    		                                                        
      september 2012 secured promissory note
    		                                                        
      accrued interest and penalty
    		                                                        
      17,000 shares and no shares issued and outstanding, respectively
    		                                             17           
      20,023,958 and 818,806 shares issued and outstanding, respectively
    		                                             835           
      liabilities and stockholders' deficiency
    		                                                        
      stockholders' deficiency
    		                                                        
      no shares issued and outstanding
    		                                                        
      15,072,911 and 818,806 shares issued and outstanding, respectively
    		                                              629          
      common stock subscribed for, 400,000 shares
    		                                              400,000          
      total stockholders' deficiency
    		                                              -3,340,459 -16,618,362 -17,258,451        
      total liabilities and stockholders' deficiency
    		                                              168,626 65,611 76,847        
      lion biotechnologies, inc.
    		                                                        
      condensed statements of operations
    		                                                        
      revenues
    		                                                        
      costs and expenses
    		                                                        
      operating expenses (including 2,139,927,
    		                                                        
      697,671, 2,360,345, 2,357,370 and 9,749,073
    		                                                        
      in share based compensation costs)
    		                                              2,459,063          
      cost of lion transaction
    		                                              6,700,000          
      research and development
    		                                              250,000 270,000 886,000        
      impairment of intangible asset
    		                                                        
      total costs and expenses
    		                                              9,409,063 1,646,425 3,136,133        
      income from operations
    		                                              -9,409,063 -1,646,425 -3,136,133        
      other income
    		                                                        
      interest expense
    		                                               -110,810 -88,472        
      change in fair value of derivative liabilities
    		                                               1,927,839 -2,548,074        
      amortization of discount on notes
    		                                                        
      cost to induce exchange transaction
    		                                                        
      financing costs
    		                                                        
      total other income
    		                                               1,319,141 -2,636,546        
      net income
    		                                              -9,409,063 -327,284 -5,772,679        
      net income per share
    		                                              -0.66 0 0.07        
      weighted-average common shares
    		                                                        
      outstanding, basic and diluted
    		                                              14,152,052 78,293,095 78,136,665        
      deposits and prepaid expenses
    		                                               8,628 34,050        
      depreciation of 5,809 and 2,704
    		                                               25,244         
      rent deposit
    		                                               16,000 16,000 16,000       
      accrued expenses - national institute of health
    		                                               616,000 866,000        
      12% secured promissory notes
    		                                               1,216,250         
      7% convertible promissory notes
    		                                               5,000,000 5,000,000        
      derivative liabilities
    		                                               8,740,110 10,667,947 6,292,388       
      78,293,095 and 77,993,591 shares issued and outstanding, respectively
    		                                               3,262 3,262        
      common shares to be issued with 12% secured promissory notes
    		                                               497,888         
      operating expenses (including 469,486,
    		                                                        
      9,211,000, 1,696,712, 9,251,302 and 13,855,121
    		                                                        
      in share-based compensation costs)
    		                                               1,376,425         
      amortization of discount on convertible notes
    		                                               -497,888         
      private placement costs
    		                                                        
      depreciation of 4,257 and 2,704
    		                                                26,797        
      intellectual property licenses, net of accumulated amortization of
    		                                                        
      217,408 and 217,408
    		                                                        
      bank overdraft
    		                                                17,619        
      operating expenses (including 1,227,227
    		                                                        
      40,302, and 15,835,268 of non-cash
    		                                                        
      share-based compensation costs)
    		                                                2,250,133        
      advance to related party
    		                                                 50,000       
      deposit
    		                                                 17,500 7,500 7,500 5,000 150 150 150 
      intellectual property licenses, net of accumulated amortization of 111,723 and 57,372
    		                                                 105,685       
      accrued interest
    		                                                 31,644       
      unsecured convertible promissory notes, net of discount
    		                                                 2,598,425       
      advances to related party
    		                                                  50,000 50,000     
      intellectual property licenses, net of accumulated amortization of 93,606 and 57,372
    		                                                  123,802      
      derivative liability
    		                                                  1,739,473 698,621 792,575 546,730   
      intellectual property licenses, net of accumulated amortization of 75,489 and 57,372
    		                                                   141,919     
      website, net of accumulated amortization of 3,667 and 2,442
    		                                                        
      intellectual property licenses, net of accumulated amortization of 57,372
    		                                                    160,036    
      due to director
    		                                                       18,137 
      website, net of accumulated depreciation of 347 and 2,442
    		                                                     1,734   
      intellectual property licenses
    		                                                     217,408 217,408 217,408 
      common stock; 0.000041666 par value; 1,800,000,000 shares authorized; 72,793,349 and 121,440,000 shares issued and outstanding, respectively
    		                                                     3,033   
      website, net of accumulated depreciation of 173
    		                                                      1,908  
      common stock; 0.000041666 par value; 1,800,000,000 shares authorized; 71,860,008 and 121,440,000 shares issued and outstanding, respectively
    		                                                      2,994 2,994 
      website, net of accumulated depreciation
    		                                                       2,081 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.